Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.49), $0.31 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $14.77 million versus the consensus estimate of $15.36 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.